NVLNF Insider Trading Activity and SEC Form 4 Filings
NVLNF insider trading summary
No open-market insider purchases or sales of Novelion Therapeutics Inc. (NVLNF) have been reported on SEC Form 4 in the past 12 months.
Latest NVLNF insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Dec 12, 2019 | Stonepine Capital, L.P. | 10% Owner | Buy | $700 (1,000 @ $0.70) |
| Dec 11, 2019 | Stonepine Capital, L.P. | 10% Owner | Buy | $28 (40 @ $0.69) |
| Dec 10, 2019 | Stonepine Capital, L.P. | 10% Owner | Buy | $4K (5,202 @ $0.69) |
| Dec 9, 2019 | Stonepine Capital, L.P. | 10% Owner | Buy | $3K (4,500 @ $0.70) |
| Dec 6, 2019 | Stonepine Capital, L.P. | 10% Owner | Buy | $28 (40 @ $0.70) |
| Dec 5, 2019 | Stonepine Capital, L.P. | 10% Owner | Buy | $4K (5,160 @ $0.70) |
| Nov 22, 2019 | Stonepine Capital, L.P. | 10% Owner | Buy | $67K (89,845 @ $0.75) |
| Oct 11, 2019 | Stonepine Capital, L.P. | 10% Owner | Buy | $65K (100,000 @ $0.65) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.